RNA News and Research

RSS

Ribonucleic acid (RNA) is a biologically important type of molecule that consists of a long chain of nucleotide units. Each nucleotide consists of a nitrogenous base, a ribose sugar, and a phosphate.

Neonatal mice-based model established that allows for the transmission of clinical SARS-CoV-2 isolates

Researchers established a neonatal mice model that enabled SARS-CoV-2 transmission.

7 Oct 2022

Study using human and animal-derived cell lines suggests human origin of SARS-CoV-2 Omicron variant

Researchers examined the replicative capacity of seven SARS-CoV-2 isolates in 17 cell lines to understand their phenotypic variations and host range.

7 Oct 2022

COVID‐19 pathology across different tissues

Researchers investigated COVID-19 pathophysiology in multiple tissues, including the lungs, kidneys, heart, and brain, for a deeper understanding of its acute and long‐term symptoms.

7 Oct 2022

Exploring the biomarker profiles in severe COVID-19

In new research, researchers estimated the D-dimer levels and characterized lymphocyte subsets and cytokine profiles in severe coronavirus disease 2019 (COVID-19) patients.

7 Oct 2022

Study suggests an immunological benefit of combining previous natural infection with vaccination against COVID-19 using a combination of different vaccine platforms

Researchers explored SARS-CoV-2-targeted immune responses among COVAC1 participants who received a novel saRNA vaccine followed by the mRNA BNT162b2 vaccine BNT162b2 vaccine, with or without prior COVID-19 history.

7 Oct 2022

New platform for gene editing may change the landscape of CRISPR-based therapeutics

A team of researchers at Northwestern University has devised a new platform for gene editing that could inform the future application of a near-limitless library of CRISPR-based therapeutics.

7 Oct 2022

Impaired immune responses not responsible for COVID-19 rebound, findings suggest

Findings from a small study of eight patients published in Clinical Infectious Diseases suggest that COVID-19 rebound is likely not caused by impaired immune responses.

6 Oct 2022

Researchers create a clinical scoring system to predict viable viral shedding after COVID-19 infection

A recent study published in the Journal of Clinical Virology developed an individualized scoring system to predict the shedding of viable SARS-CoV-2 from COVID-19 positive patients, which would help to determine personalized isolation strategies.

6 Oct 2022

Intranasal vaccine represents an effective broad-spectrum COVID-19 vaccine strategy

Researchers evaluated the efficacy of dNS1-RBD, a novel intranasal COVID-19 vaccine.

6 Oct 2022

Environmental surveillance of SARS-CoV-2 could predict COVID-19 cases

A new study reported that coronavirus disease 2019 (COVID-19) cases could be predicted by environmental surveillance.

6 Oct 2022

Stanford researchers create new technique for controlling protein production

Thanks to new RNA vaccines, we humans have been able to protect ourselves incredibly quickly from new viruses like SARS-CoV-2, the virus that causes COVID-19.

5 Oct 2022

Researchers uncover an intriguing previously unknown ability of Swiss army knife enzyme

Blue-green algae (AKA cyanobacteria) have a superpower which likely helps them be highly successful as invaders of waterways.

5 Oct 2022

Researchers discover potential therapeutic target for deadly brain tumors

Researchers at VCU Massey Cancer Center discovered a cellular partnership that drives the growth of deadly brain tumors and could potentially serve as a novel target for disease treatment.

5 Oct 2022

Study shows the important role of hepatocyte adenosine kinase in NAFLD progression

A study led by Texas A&M AgriLife Research provides compelling evidence of the important role of hepatocyte adenosine kinase in the progression of nonalcoholic fatty liver disease, NAFLD.

5 Oct 2022

Key biophysical attributes of a self-amplifying viral RNA vaccine developed for SARS-CoV-2

Researchers used various analytical characterization techniques to determine the biophysical attributes of the Imperial College London self-amplifying viral RNA vaccine (IMP-1) developed for SARS-CoV-2.

5 Oct 2022

Study shows SARS-CoV-2 infects human adipose tissue and undergoes productive infection in fat cells

Researchers demonstrated infection of human adipose tissue by SARS-CoV-2.

5 Oct 2022

Study identifies a potential biological marker to help diagnose postpartum depression

A federally funded study led by Johns Hopkins Medicine researchers discovered that communication among cells is altered in pregnant women who go on to develop postpartum depression (PPD) after giving birth.

4 Oct 2022

Multiomic comparison shows a reduction in circulating monocytes correlated with persistent post-COVID-19 pulmonary fibrosis

In a new study, researchers identified distinguishing immune features of coronavirus disease 2019 (COVID-19) in patients with late-resolving pulmonary fibrosis (LR COVID-PF) and early-resolving (ER COVID-PF).

4 Oct 2022

Can you shed infectious SARS-CoV-2 virions even if COVID vaccinated?

Researchers in the United States published a study in the journal PLOS Pathogens that examined the shedding of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virions despite vaccination against it.

4 Oct 2022

How COVID-19 affects the female reproductive system

A new review in the Biology of Reproduction journal analyzed the relationship between the immune system and the female reproductive system while focusing on the effects of COVID-19-associated immune responses on the reproductive system. The study searched PubMed to identify peer-reviewed literature in English up to May 2022 and finally included 83 studies.

3 Oct 2022

RNA News and Research

Further Reading

Neonatal mice-based model established that allows for the transmission of clinical SARS-CoV-2 isolates

Study using human and animal-derived cell lines suggests human origin of SARS-CoV-2 Omicron variant

COVID‐19 pathology across different tissues

Exploring the biomarker profiles in severe COVID-19

Study suggests an immunological benefit of combining previous natural infection with vaccination against COVID-19 using a combination of different vaccine platforms

New platform for gene editing may change the landscape of CRISPR-based therapeutics

Impaired immune responses not responsible for COVID-19 rebound, findings suggest

Researchers create a clinical scoring system to predict viable viral shedding after COVID-19 infection

Intranasal vaccine represents an effective broad-spectrum COVID-19 vaccine strategy

Environmental surveillance of SARS-CoV-2 could predict COVID-19 cases

Stanford researchers create new technique for controlling protein production

Researchers uncover an intriguing previously unknown ability of Swiss army knife enzyme

Researchers discover potential therapeutic target for deadly brain tumors

Study shows the important role of hepatocyte adenosine kinase in NAFLD progression

Key biophysical attributes of a self-amplifying viral RNA vaccine developed for SARS-CoV-2

Study shows SARS-CoV-2 infects human adipose tissue and undergoes productive infection in fat cells

Study identifies a potential biological marker to help diagnose postpartum depression

Multiomic comparison shows a reduction in circulating monocytes correlated with persistent post-COVID-19 pulmonary fibrosis

Can you shed infectious SARS-CoV-2 virions even if COVID vaccinated?

How COVID-19 affects the female reproductive system

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo